Suppr超能文献

转基因食品与过敏

Genetically modified foods and allergy.

作者信息

Lee T H, Ho H K, Leung T F

机构信息

Allergy Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.

出版信息

Hong Kong Med J. 2017 Jun;23(3):291-5. doi: 10.12809/hkmj166189. Epub 2017 May 5.

Abstract

2015 marked the 25th anniversary of the commercial use and availability of genetically modified crops. The area of planted biotech crops cultivated globally occupies a cumulative two billion hectares, equivalent to twice the land size of China or the United States. Foods derived from genetically modified plants are widely consumed in many countries and genetically modified soybean protein is extensively used in processed foods throughout the industrialised countries. Genetically modified food technology offers a possible solution to meet current and future challenges in food and medicine. Yet there is a strong undercurrent of anxiety that genetically modified foods are unsafe for human consumption, sometimes fuelled by criticisms based on little or no firm evidence. This has resulted in some countries turning away food destined for famine relief because of the perceived health risks of genetically modified foods. The major concerns include their possible allergenicity and toxicity despite the vigorous testing of genetically modified foods prior to marketing approval. It is imperative that scientists engage the public in a constructive evidence-based dialogue to address these concerns. At the same time, improved validated ways to test the safety of new foods should be developed. A post-launch strategy should be established routinely to allay concerns. Mandatory labelling of genetically modified ingredients should be adopted for the sake of transparency. Such ingredient listing and information facilitate tracing and recall if required.

摘要

2015年是转基因作物商业化使用和上市25周年。全球种植的转基因作物累计种植面积达20亿公顷,相当于中国或美国国土面积的两倍。许多国家广泛消费源自转基因植物的食品,在所有工业化国家,转基因大豆蛋白被广泛用于加工食品。转基因食品技术为应对当前和未来食品及医药领域的挑战提供了一种可能的解决方案。然而,有一种强烈的焦虑暗流,认为转基因食品对人类消费不安全,有时这种焦虑因几乎没有确凿证据的批评而加剧。这导致一些国家因认为转基因食品存在健康风险而拒绝接受用于救灾的食品。主要担忧包括,尽管转基因食品在上市前经过了严格测试,但它们可能具有致敏性和毒性。科学家必须与公众进行建设性的、基于证据的对话,以解决这些担忧。与此同时,应开发经过改进的、经过验证的新食品安全性测试方法。应常规制定上市后策略以减轻担忧。为了提高透明度,应强制标注转基因成分。这种成分列表和信息便于在需要时进行追踪和召回。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验